PENUMBRA INC (PEN)
US70975L1070 - Common Stock
Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Global Healthcare...
Penumbra Becomes Oversold (PEN)
Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after...
PEN July 2025 Options Begin Trading
Notable Friday Option Activity: PEN, PRGS, ULTA
Noteworthy Friday Option Activity: ATMU, NAT, PEN
Penumbra stock cut to Hold at J.P. Morgan (NYSE:PEN)
Penumbra (PEN) stock slips as J.P. Morgan downgrades the medical device company as its Q4 2023 revenue falls short of estimates. Read more here.
Penumbra GAAP EPS of $1.38 beats by $0.67, revenue of $284.7M misses by $1.83M (NYSE:PEN)
Penumbra (PEN) exceeds Q4 earnings expectations, but misses on revenue.
Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth...
Penumbra Breaks Above 200-Day Moving Average - Bullish for PEN
Notable Wednesday Option Activity: AVNW, PEN, BAX
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full...
Commit To Buy Penumbra At $190, Earn 6.7% Annualized Using Options
Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P. Morgan 42nd Annual Healthcare...
Noteworthy Friday Option Activity: ANET, NCNO, PEN
Penumbra, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Piper Sandler 35th Annual Healthcare...
Monday Sector Leaders: Medical Instruments & Supplies, Cigarettes & Tobacco Stocks
Relative Strength Alert For Penumbra
Noteworthy Wednesday Option Activity: APP, NXST, PEN
Penumbra Moves Up In Market Cap Rank, Passing Bath & Body Works
Penumbra GAAP EPS of $0.23 (NYSE:PEN)
Read the Penumbra press release on its Q3 2023 financial results, reporting $0.23 GAAP EPS and $270.9M revenue, surpassing expectations by $5.76M.
Penumbra, Inc. Reports Third Quarter 2023 Financial Results
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third quarter...
NEW LATE BREAKING DATA DEMONSTRATE PENUMBRA'S COMPUTER ASSISTED VACUUM THROMBECTOMY TECHNOLOGY FOR PULMONARY EMBOLISM IMPROVED PATIENT OUTCOMES
/PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced the latest STRIKE-PE data evaluating...